Rep. Norm Thurston — Voting Record

Bill

Number

H.B. 258 Second Substitute (2018GS)

Sponsor

Rep. Christensen, L.

Final action

Governor Signed 3/19/2018

Outcome

Became law — signed by Gov. Gary R. Herbert

Summary

What it does

• This bill:
• requires a facility that performs screening or diagnostic mammography to provide a patient who has dense breast tissue with a notification regarding that report.

Every vote on this bill

Bill text

WOMEN'S CANCER SCREENING NOTIFICATION AMENDMENTS
GENERAL SESSION
STATE OF UTAH
Chief Sponsor: LaVar Christensen
Senate Sponsor: 
Curtis S. Bramble
Cosponsors:
Cheryl K. Acton
Carl R. Albrecht
Kay J. Christofferson
Kim F. Coleman
James A. Dunnigan
Rebecca P. Edwards
Gage Froerer
Francis D. Gibson
Keith Grover
Stephen G. Handy
Gregory H. Hughes
Eric K. Hutchings
Ken Ivory
Bradley G. Last
A. Cory Maloy
Jefferson Moss
Merrill F. Nelson
Michael E. Noel
Derrin R. Owens
Lee B. Perry
Jeremy A. Peterson
Dixon M. Pitcher
Val K. Potter
Susan Pulsipher
Tim Quinn
Paul Ray
Scott D. Sandall
Mike Schultz
V. Lowry Snow
Keven J. Stratton
Christine F. Watkins
R. Curt Webb
Brad R. Wilson
Mike Winder
LONG TITLE
General Description:
This bill amends provisions of the Mammogram Quality Assurance Act.
Highlighted Provisions:
This bill:
▸ requires a facility that performs screening or diagnostic mammography to provide a
patient who has dense breast tissue with a notification regarding that report.
Money Appropriated in this Bill:
None
Other Special Clauses:
None
Utah Code Sections Affected:
AMENDS:
26-21a-203
, as last amended by Laws of Utah 2012, Chapter 338
26-21a-205
, as last amended by Laws of Utah 2009, Chapter 183
ENACTS:
26-21a-206
, Utah Code Annotated 1953
Be it enacted by the Legislature of the state of Utah:
Section 1. Section 
26-21a-203
 is amended to read:
26-21a-203.
Department rulemaking authority.
The department shall make rules under Title 63G, Chapter 3, Utah Administrative
Rulemaking Act:
(1) establishing quality assurance standards for all facilities performing screening or
diagnostic mammography and developing mammogram x-ray films, including 
notification and
procedures for clinical follow-up of abnormal mammograms;
(2) providing for:
(a) collection and periodic reporting of mammography examinations and clinical
follow-up data to the department;
(b) certification and revocation of certification of mammogram facilities;
(c) inspection of mammogram facilities, including entry of agents of the department
into the facilities for inspections;
(d) setting fees for certification; and
(e) an appeal process regarding department certification decisions; and
[
(3) the following information may be included in mammography results sent to a
patient with dense breast tissue:
]
[
"Mammography is the only breast cancer screening examination which has been
shown in multiple randomized clinical trials to reduce death rate from breast cancer. However,
it is not a perfect test, specifically in women with dense breast tissue. Because your
mammogram demonstrates that you have dense breast tissue, you may benefit from
supplementary screening tests, depending on your personal risk factors and family history. 
Although other screening tests may find additional cancers, they may not necessarily increase
survival. Nevertheless, you should discuss your mammography results with your health care
provider. A copy of your mammography report has been sent to your health care provider's
office. Please contact your health care provider if you have any questions or concerns about
this notice."
] 
(3) requiring a facility that is certified under Section 
26-21a-204
 to comply with the
notification requirement described in Section 
26-21a-206
.
Section 2. Section 
26-21a-205
 is amended to read:
26-21a-205.
Department duties.
The department shall:
(1) enforce rules established under this part;
(2) implement and enforce the notice requirement in Section 
26-21a-206
;
[
(2)
] 
(3)
 authorize qualified department agents to conduct inspections of mammogram
facilities under department rules;
[
(3)
] 
(4)
 collect and credit fees for certification [
under
] 
established by the department
in accordance with
 Section 
63J-1-504
; and
[
(4)
] 
(5)
 provide necessary administrative and staff support to the committee.
Section 3. Section 
26-21a-206
 is enacted to read:
 26-21a-206.
Women's cancer screening notification requirement.
(1) As used in this section, "dense breast tissue" means heterogeneously dense tissue or
extremely dense tissue as defined in the Breast Imaging and Reporting Data System established
by the American College of Radiology.
(2) A facility that is certified under Section 
26-21a-204
 shall include the following
notification and information with a mammography result provided to a patient with dense
breast tissue:
"Your mammogram indicates that you have dense breast tissue. Dense breast tissue is
common and is found in as many as half of all women. However, dense breast tissue can make
it more difficult to fully and accurately evaluate your mammogram and detect early signs of
possible cancer in the breast. This information is being provided to inform and encourage you
to discuss your dense breast tissue and other breast cancer risk factors with your health care
provider. Together, you can decide what may be best for you. A copy of your mammography
report has been sent to your health care provider. Please contact them if you have any questions
or concerns about this notice."